Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2978761 | The Journal of Thoracic and Cardiovascular Surgery | 2016 | 11 Pages |
Abstract
Less residual primary cancer in response to preoperative therapy is associated with a linear increase in survival after esophagectomy for locally advanced esophageal adenocarcinoma; however, survival is poorer than for resected early-stage cancers. Therefore, for patients with poor prognostic indicators, including higher percentage of residual primary cancer, the role of adjuvant therapy needs to be further examined in an attempt to improve survival.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Siva MD, PhD, Thomas W. MD, John PhD, John R. MD, Lisa A. MS, Sudish C. MD, PhD, David MD, Gregory MD, Michael P. MD, Eugene H. MD,